Table 2 Univariate and multivariate analyses of the disease-free survival of the 161 TNBC patients
Variable | Â | Disease-free survival | ||
|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR (95% CI) | P value | HR (95% CI) | P value | |
Age ≤ 40 years old | 1.090 (0.527–2.254) | 0.817 |  |  |
Family history of cancer | 0.649 (0.290–1.448) | 0.291 |  |  |
Menstruating | 1.321 (0.738–2.366) | 0.348 |  |  |
History of other neoplasms | 1.321 (0.320–5.449) | 0.700 |  |  |
Stage III disease | 3.918 (2.203–6.967) | 0.000 | 2.163 (1.121–4.172) | 0.021 |
T3/ T4 | 2.083 (1.098–3.951) | 0.025 | 0.870 (0.357–2.119) | 0.771 |
Lymph node metastasis | 4.502 (2.287–8.863) | 0.000 | 2.890 (1.330–6.277) | 0.007 |
Poor tumor differentiation | 1.426 (0.683–2.979) | 0.345 |  |  |
Vascular invasion | 2.983 (1.639–5.429) | 0.000 | 1.558 (0.731–3.320) | 0.255 |
Low ANGPTL4 expression | 2.283 (1.280–4.075) | 0.004 | 2.005 (1.121–3.585) | 0.019 |